Rebirth: Super Banking System - Chapter 2382 - 2222: Soaring
Chapter 2382: Chapter 2222: Soaring
At this moment.
Major European and American pharmaceutical companies feel like they’ve eaten shit.
Heartache.
Frustration.
Really want to hit someone! These months, they’ve been hoping for some medical incident to occur, so they could fiercely criticize and impede the introduction.
However.
Facts have proved they overthought it. So far, the cured patients haven’t shown adverse reactions, especially many severe patients getting out of bed.
On the news every day.
Today.
Three.
Tomorrow.
Five.
The day after tomorrow.
A dozen… Time and again it assaults their nerves—people who were unable to live independently, paralyzed for years, can now have agile minds.
Talk.
Chat.
Having lively conversations.
Damn!
Can your drug effects be a little restrained?
“Xie Te.”
“Fuck.”
“Damn.”
“…”
In the office, they don’t know how many times they’ve cursed these lines, the anger in their hearts! It cut off such a big financial path just for that little profit.
This medicine.
If they operated it, they could earn more than ten times what Myanmar Medical Group is making now, even more. They really wanted to find that company.
Say:
Three times.
No.
Five times the current price, just sell to me, let’s get rich together, the nearly billion-dollar order from Huaxia on the news seems close.
However.
In their view.
Cabbage!
Almost free!
Slack selling!
If they managed it, they’d sell for at least fifty billion dollars, nearly four hundred billion RMB, currently only six hundred, although the drug is not theirs, they feel distressed!
The more they think, the more painful, wasting precious resources!
…
Meanwhile.
In the United States.
Washington.
White House.
Facing public demands, the President, who has been in office for over a year and has already made healthcare reform a main focus of his term, is laughing inwardly.
It’s almost unimaginable before.
For no other reason.
Capital.
The pharmaceutical giant is powerful, disrupting their interests is undoubtedly seeking discomfort, but now it’s different, Myanmar Medical Group has broken the pattern.
Firstly.
Transcription Fluid.
Greatly reduced subsidies for diseases like cancer and leukemia, it’s a godsend, he was worried the consortium wouldn’t just sit idly by.
However.
The fact is: The consortium quite enjoyed watching!
Well.
Though puzzled, it fits his intentions. This time, the emergence of Alzheimer’s treatment is another unexpected good news.
Thus.
It can save a lot of money.
“I think we should follow public opinion and allow the listing, how do you feel?”
“Okay.”
“Sure.”
“…”
His cabinet members naturally support it; the tide of public opinion is overwhelming. More importantly, the pharmaceutical giants seem to have chosen to give up resistance.
No lobbying.
No obstruction.
No underhanded tricks.
Therefore.
They’re so consistent, but some are worried about it.
To this end.
Someone immediately thought of a solution, “No problem, before treatment, you can sign a waiver agreement with their family, take the risk yourself, we don’t care.”
“Moreover.”
“Only recommend usage for severe patients. For early and mid-stage patients, we do not advocate using the specially introduced treatment drugs.”
Upon hearing.
Everyone nodded.
This matter.
They don’t want to cause any trouble; those pharmaceutical giants seem peaceful now, but who knows if they’re conspiring something, can’t be careless.
Currently, the main protesters are also the families of severe patients.
In short.
Being cautious is good.
…
Three days later.
A message spread from Washington, after unanimous decision by the authorities, specially introduced Alzheimer’s treatment drugs for severe patients.
Instantly.
Public opinion debated.
“Severe? What about mild?” someone questioned.
Immediately.
Someone answered.
“Naturally, go directly to Myanmar, it’s obvious the White House there doesn’t intend to take too much responsibility, the specially introduced drug listing is itself a risky matter.”
“Very cunning.”
“Very White House-like.”
“Right.”
“…”
Besides complaints, people weren’t too concerned, this is a step forward, for early and mid-stage patients, a trip to Myanmar would also be nice.
After all.
Myanmar.
Now considered a world-class travel destination, patients are mostly elderly. For elderly people, going out to see the world, while healing their illness, is pretty good!
Thus.
They’re content.
“It’s also good to visit Myanmar, seeing what kind of magical country it is, and Huaxia, never been to Asia in my life, travel a bit.”
“Indeed.”
“Can’t, better book the tickets soon, otherwise it’ll be next semester.”
“…”
At once.
Many who were watching, seeing the specially introduced drugs aren’t for early or mid-stage, quickly went to book on Myanmar Medical Group’s official website.
Then.
Based on the appointment date, booked plane tickets and hotel.
…
Europe.
Some countries.
Two days later, also began publishing similar special permits, only allowing severe domestic treatment. People saw this and got used to it, no harm.
A trip.
Also quite good.
Meanwhile.
More countries followed suit, as Europe and America introduced, they couldn’t hold back, obviously inappropriate. Many fully introduced.
Early stage.
Middle stage.
Late stage.
All can be treated domestically. This type mostly includes African countries, firstly as major investors they need to show face, secondly they don’t have other options.
Already poor, going to Myanmar.
– Plane ticket.
– Board and lodging.
– Medicine.
– Consumption.
These four items can cost them a lot of foreign exchange reserves, might as well introduce it, directly saving three of the major items, saving is earning.
No choice.
Poor.
Have to tighten the belt to live!
…
Just like that.
Two weeks.
Over eighty countries and regions globally permitted the introduction of Alzheimer’s treatment drugs for domestic severe patient treatment, and what followed.
Were orders.
Three hundred.
Five hundred.
A thousand.
One thousand five hundred.
…
By mid-March, Myanmar Medical Group received orders exceeding one thousand eight hundred billion RMB, moving towards thirty billion dollars rapidly.
This figure is envy-inducing to others.
However.
European and American pharmaceutical giants, not witnessing merely bleeding, but blood streaming profusely. Because of this, Myanmar Medical Group’s stocks began to soar.
Two weeks.
Thirty percent.
On its already considerable market value, it’s already very impressive.
As a result.
Huaxia’s many stock investors became excited.
“Haha, won again.”
“Great!”
“This company indeed didn’t disappoint me, previously worrying Transcription Fluid would be its end, unexpectedly, they have this backup.”
“Amazing!”
“Envious!”
“Sigh! Sold too early!”
“…”
Excitement.
Envy.
Sighs.
Various emotions rise and fall, with Myanmar stock exchanges, many made a fortune, of course, some felt it’s already high and left.
Now.
Could not help regretting.
“Counting still Myanmar stocks are stable, from the day of birth, they’ve been steadily rising, and mainly not relying on market manipulator actions, but value realization.”
“Back then!”
“Entered at market opening, now one million goes in, at least six million comes out, sigh! If known, wouldn’t have sold, long-term holding and steady income.”
